文献速递核素与放射性配体治疗放射性药物与辐射防护

进食对唾液腺PSMA配体摄取的影响

The effect of eating on the uptake of PSMA ligands in the salivary glands.
PubMed 文献 · EJNMMI Res · 2021-09-26

本研究纳入10例已接受[18F]DCFPyl PET/CT的前列腺癌患者,在再次扫描时于示踪剂给药前1分钟至给药后10分钟咀嚼吞咽甜/脂/酸性食物。结果显示干预扫描腮腺PSMA摄取轻度增加(SULmean +7.1%,SULmax +9.2%,p<0.05),颌下腺无显著差异。作者建议PSMA配体核素治疗给药及早期生物分布阶段避免味觉刺激。

要点

  • 进食仅轻度增加腮腺对[18F]DCFPyl的摄取,颌下腺无显著变化。
  • 腮腺摄取增加幅度为SULmean +7.1%、SULmax +9.2%(p<0.05)。
  • 建议PSMA配体核素治疗给药及早期生物分布阶段避免味觉刺激。

核心结论

  • 进食仅轻度增加[18F]DCFPyl在腮腺的摄取,颌下腺无显著差异。
  • 建议PSMA配体核素治疗给药及早期生物分布阶段避免味觉刺激以减少可避免的额外毒性风险。

研究设计与样本

  • 10例已接受全身[18F]DCFPyl PET/CT评估前列腺癌的患者,在1个月内重复(干预)PET/CT扫描。
  • 干预扫描时患者从甜/脂/酸性食物中选择,从示踪剂给药前1分钟至给药后10分钟咀嚼吞咽。
  • 两次扫描数据通过在主唾液腺放置VOI并使用相对阈值分割进行分析。

主要发现

  • 干预扫描较基线扫描腮腺PSMA摄取轻度增加:SULmean +7.1%、SULmax +9.2%(p<0.05)。
  • 颌下腺PSMA摄取无显著差异。

临床怎么用

  • PSMA配体核素治疗给药及早期生物分布阶段建议避免味觉刺激。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: PSMA-directed therapy for metastatic prostate cancer is gaining adoption as a treatment option. However, accumulation of 177Lu/225Ac-PSMA in the salivary glands remains a problem, with risk of dose-limiting xerostomia and potentially severe effect on the quality of life. Gustatory stimulation is an approach that has commonly been used in radioactive iodine therapy to reduce accumulation in the salivary glands. However, based on theoretical differences in biodistribution, it was hypothesized that this could potentially lead to adverse increased toxicity for PSMA-ligand therapy. The primary objective of this work was to determine if gustatory stimulation by eating an assortment of sweet/fatty/acidic foods during the biodistribution phase of [18F]DCFPyl could result in a clinically relevant (> 30%) change in the uptake of the tracer in the salivary glands. METHODS: 10 patients who already received a whole-body [18F]DCFPyl PET/CT scan for evaluation of prostate cancer, underwent a repeat (intervention) PET/CT scan within a month of the first (control) scan. During the intervention scan, patients chose from an assortment of sweet/fatty/acidic foods, which they then chewed and swallowed for a period of time starting 1 min before tracer administration to 10 min thereafter. Data from both scans were analyzed by placing VOIs on the major salivary glands and segmenting them using relative thresholds. RESULTS: A slight increase in PSMA uptake in the parotid glands was observed on the intervention scan when compared to the baseline scan (+ 7.1% SULmean and + 9.2% SULmax, p < 0.05). No significant difference in PSMA uptake in the submandibular glands was seen. CONCLUSIONS: Eating only slightly increases uptake of [18F]DCFPyl in the parotid glands. We nonetheless recommend refraining from gustatory stimulation during the administration and early biodistribution phase of radionuclide therapy with PSMA-ligands to reduce the risk of avoidable additional toxicity.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Mohan V, Bruin NM, van de Kamer JB, et al. The effect of eating on the uptake of PSMA ligands in the salivary glands. EJNMMI Res. 2021. PMID: 34568982. doi:10.1186/s13550-021-00838-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。